Lantheus to receive supply of LEU-derived Mo-99 from ANSTO

12/20/2009 | AuntMinnie.com (free registration)

The Australian Nuclear Science and Technology Organisation has agreed to provide U.S. firm Lantheus Medical Imaging with molybdenum-99 derived from low-enriched uranium for use in its TechneLite generator line being marketed in U.S. and Canada. Lantheus and ANSTO are working with U.S. and Canadian regulators to obtain the necessary approvals for the distribution of LEU-derived Mo-99 in U.S. and Canadian markets.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA